The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer Schering Pharma; Merck Serono; Novartis; Roche
Consulting or Advisory Role - Bayer Schering Pharma; Merck Serono; Prestizia
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer Schering Pharma; Merck Serono; Sanofi
Impact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trial.
 
Valerie Boige
No Relationships to Disclose
 
Caroline Mollevi
No Relationships to Disclose
 
Nathalie Chaput
No Relationships to Disclose
 
Sophie Gourgou
No Relationships to Disclose
 
David Azria
No Relationships to Disclose
 
Jean-François Seitz
Consulting or Advisory Role - Celgene; Lilly; Novartis; Pfizer; Roche; Sanofi
Research Funding - Merck Serono (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Ludovic Bigot
No Relationships to Disclose
 
Beata Juzyna
No Relationships to Disclose
 
Isabelle Miran
No Relationships to Disclose
 
Jean-Pierre Gerard
No Relationships to Disclose
 
Pierre Laurent-Puig
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono; Roche